Vor Biopharma
Clinical trials sponsored by Vor Biopharma, explained in plain language.
-
New drug aims to tame Sjögren's Flare-Ups in major trial
Disease control Recruiting nowThis phase 3 study tests whether telitacicept can reduce disease activity in adults with active primary Sjögren's disease. About 250 participants will receive either the drug or a placebo for 48 weeks. The main goal is to see if telitacicept improves symptoms like dry eyes and mo…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug trial aims to ease daily struggles of muscle weakness disease
Disease control Recruiting nowThis study tests a drug called telitacicept in 180 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo for 24 weeks to see if it improves daily activities like walking and talking. The goal is to contro…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated May 19, 2026 12:00 UTC